Global Intra Aortic Balloon Pumps Market – Industry Trends and Forecast to 2030

Intra Aortic Balloon Pumps Market Analysis and Size

According to the World Health Organization (WHO), Cardiovascular Diseases (CVDs) are the leading cause of death globally, accounting for 17.9 million deaths per year. This represents 31% of all global deaths. For instance, in the U.S., CVDs are responsible for approximately one in every four deaths, making it the leading cause of death in the country.

Data Bridge Market Research analyzes that the global intra aortic balloon pumps market, which was USD 268.31 million in 2022, would rocket up to USD 381.56 million by 2030, and is expected to undergo a CAGR of 4.5% during the forecast period. This indicates the market value. “Coronary Artery Diseases” dominates the indication segment of the market owing to the growing cases of cardiac disorders and treatment methods.

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Intra Aortic Balloon Pumps Market Scope and Segmentation

Market Definition

Intra-Aortic Balloon Pump (IABP) improves the oxygen supply by increasing the bloodstream to the coronary conduits and relaxing the patients with myocardial ischemia and dysrhythmias. It also has a major role in supporting the left ventricular function and cardiogenic shock treatment.

Global Intra Aortic Balloon Pumps Market Dynamics

Drivers

• Increasing Adoption in Emerging Economies

The increasing adoption of IABP devices in emerging economies, such as China and India, is expected to create significant growth opportunities for market players in the coming years. This is due to the growing healthcare infrastructure and increasing healthcare spending in these regions.

• Rising Demand for Minimally Invasive Surgical Procedures

The trend towards minimally invasive surgical procedures is driving the demand for IABPs, as they can be used in less invasive procedures compared to traditional open-heart surgery.

• Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases, such as coronary artery disease and heart failure, is a major driver for market growth as IABPs are used in the treatment of these conditions.

• Growing Geriatric Population

The aging global population is another driver of the IABP market, as older adults are more likely to suffer from cardiovascular diseases and may require treatment with IABPs.

Opportunities

• Growing Demand for Portable and Wireless IABP Devices

There is a growing demand for portable and wireless IABP devices that can be used in various settings, including emergency rooms, ambulances, and remote locations. This presents an opportunity for companies to develop and market such devices.

• Increasing Adoption of IABPs in Developing Countries

The adoption of IABPs is increasing in developing countries due to the growing healthcare infrastructure and increasing healthcare spending in these regions. This presents an opportunity for companies to expand their reach and tap into these markets.

• Technological Advancements in IABP Devices

The development of new and advanced IABP devices, such as those with real-time monitoring and predictive analytics capabilities, presents an opportunity for companies to differentiate their products and gain a competitive edge.

Restraint/Challenge

• High cost of IABP devices

The high cost of IABP devices and complications associated with IABP therapy are the factors expected to restrain market growth and will further challenge cardiac disease treatment. In addition, the lack of favorable reimbursement scenarios, stringent regulations for the approval of IABP products and devices, and the lack of skilled professionals in developing economies are projected to challenge market growth in the forecast period of 2023-2030.

The global intra aortic balloon pumps market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market, contact Data Bridge Market Research for an analyst brief. Our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In July 2021, MAQUET Holding announced the launch of its new CARDIOSAVE Hybrid Intra-Aortic Balloon Pump (IABP) System in Europe
• In March 2021, Getinge announced the launch of its new Maquet Cardiosave IABP with IntelliSync+ Console System in the U.S.
• In February 2021, Medtronic announced the launch of its new SenSight Directional Mechanical Lead for the Attain Stability Quad MRI SureScan Left Heart Lead

Global Intra Aortic Balloon Pumps Market Scope

The global intra aortic balloon pumps market is segmented into three notable segments based on product type, indication, and end-user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Intra – Aortic Balloon Pump (IABP) Console
• Intra – Aortic Balloon Pump (IABP) Catheters
• Introducer Tray

 Indication

• Coronary Artery Diseases
• Unstable Angina
• Myocardial Infarction (NSTEMI)
• Chronic Heart Failure

End User

• Hospital
• Ambulatory Surgical Centres
• Independent Catheterization Labs

Global Intra Aortic Balloon Pumps Market Regional Analysis/Insights

The global intra aortic balloon pumps market is analyzed and market size insights and trends are provided by country, product type, indication, and end-user as referenced above.

The countries covered in this market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.

North America dominates the global intra aortic balloon pumps market due to the strong base of healthcare facilities, the strong presence of major players in the market, the extraordinary healthcare infrastructure, and the large pool of people having cardiac disorders.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for treatment, the large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global intra aortic balloon pumps market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the market.

Competitive Landscape and Global Intra Aortic Balloon Pumps Market Share Analysis

The global intra aortic balloon pumps market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major market players operating in the global intra aortic balloon pumps market are:

• Teleflex Incorporated. (U.S.)
• MAQUET Holding B.V. & Co. KG. (Germany)
• Zeon Corporation (Japan)
• Tokai Medical Products, Inc. (Japan)
• SENKO MEDICAL INSTRUMENT Mfg. CO., Ltd. (Japan)
• InterValve Medical Inc. (U.S.)
• Insightra Medical, Inc. LLC (U.S.)
• Getinge AB (Sweden)
• Terumo Medical Corporation (Japan)
• W. L. Gore & Associates, Inc. (U.S.)
• Lepumedical.com (China)
• Medtronic (Ireland)
• Abbott (U.S.)
• Boston Scientific Corporation (U.S.)
• Edwards Lifesciences Corporation (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Berlin Heart (Germany)
• CardiacAssist, Inc. (U.S.)
• ReliantHeart Inc. (U.S.)

SKU-66317